Kalvista Pharmaceuticals Announces Proposed Offering Of $110.0 Million Of Convertible Senior Notes
View all comments(0)
Sept 24 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:
KALVISTA PHARMACEUTICALS ANNOUNCES PROPOSED OFFERING OF $110.0 MILLION OF CONVERTIBLE SENIOR NOTES
KALVISTA PHARMACEUTICALS INC - PROCEEDS TO FUND WORKING CAPITAL AND EKTERLY COMMERCIALIZATION
KALVISTA PHARMACEUTICALS INC - NOTES MATURE ON OCTOBER 1, 2031
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Rocket Lab Earnings Greatly Exceed Expectations, Ignoring Risks as Stock Price Surges?

Tradingkey






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.